Skip to content

Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane

C20H31F2N5O2 — CID 157030522

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane
SMILESCC(N)c1cnn2cc(CNC(=O)OC(C)(C)C)nc2c1.FC1(F)CCCCC1
InChIInChI=1S/C14H21N5O2.C6H10F2/c1-9(15)10-5-12-18-11(8-19(12)17-6-10)7-16-13(20)21-14(2,3)4;7-6(8)4-2-1-3-5-6/h5-6,8-9H,7,15H2,1-4H3,(H,16,20);1-5H2
InChIKeyNVNTVYVPYZBFAD-UHFFFAOYSA-N
MW411.50 g/mol
LogP4.36
Rot. Bonds3

About Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane

Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane (PubChem CID 157030522) has the molecular formula C20H31F2N5O2 and a molecular weight of 411.50 g/mol. Its IUPAC name is tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane.

Molecular Properties

Compound NameTert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane
PubChem CID157030522
Molecular FormulaC20H31F2N5O2
Molecular Weight411.50 g/mol
Exact Mass411.24
IUPAC Nametert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane
SMILESCC(N)c1cnn2cc(CNC(=O)OC(C)(C)C)nc2c1.FC1(F)CCCCC1
InChIInChI=1S/C14H21N5O2.C6H10F2/c1-9(15)10-5-12-18-11(8-19(12)17-6-10)7-16-13(20)21-14(2,3)4;7-6(8)4-2-1-3-5-6/h5-6,8-9H,7,15H2,1-4H3,(H,16,20);1-5H2
InChIKeyNVNTVYVPYZBFAD-UHFFFAOYSA-N
XLogP4.36
TPSA94.54 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500411.50
LogP ≤ 54.36
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane?
The IUPAC name of Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane (CID 157030522) is tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane.
What is the SMILES notation for Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane?
The canonical SMILES for Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane is CC(N)c1cnn2cc(CNC(=O)OC(C)(C)C)nc2c1.FC1(F)CCCCC1.
What is the InChIKey of Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane?
The InChIKey is NVNTVYVPYZBFAD-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H21N5O2.C6H10F2/c1-9(15)10-5-12-18-11(8-19(12)17-6-10)7-16-13(20)21-14(2,3)4;7-6(8)4-2-1-3-5-6/h5-6,8-9H,7,15H2,1-4H3,(H,16,20);1-5H2.
What are the key properties of Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane?
Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane has a molecular weight of 411.50 g/mol, XLogP of 4.36, 3 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for Tert-butyl N-[[7-(1-aminoethyl)imidazo[1,2-b]pyridazin-2-yl]methyl]carbamate;1,1-difluorocyclohexane is sourced from PubChem (CID 157030522), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.